发明名称 Composition useful for treating and preventing hypercholesterolaemia, rheumatoid arthritis and/or neurodegenerative disorders, comprises first compound e.g. celecoxib and etoricoxib, and second compound e.g. indoprofen and mefenamic acid
摘要 <p>Composition comprises (a) at least one first compound comprising celecoxib, etoricoxib, lumiracoxib, parecoxib, rofecoxib, valdecoxib, valicoxib, and (b) at least one second compound comprising: e.g. indoprofen, ibuproxam, ketoprofen, ketorolac, loxoprofen, naproxen, naproxen sodium, oxaprozin, pirprofen, suprofen, tiaprofenic acid and alminoprofen; salicylamide and salicyl salicylate; aceclofenac, acemetacin and alclofenac; mefenamic acid, flufenamic acid and meclofenamic acid; ampyrone, azapropazone and clofezone; and droxicam, lornoxicam, meloxicam, piroxicam, tenoxicam, and nimesulide. Composition comprises (a) at least one first compound comprising celecoxib, etoricoxib, lumiracoxib, parecoxib, rofecoxib, valdecoxib, valicoxib, and (b) at least one second compound comprising: indoprofen, ibuproxam, ketoprofen, ketorolac, loxoprofen, naproxen, naproxen sodium, oxaprozin, pirprofen, suprofen, tiaprofenic acid, alminoprofen, benoxaprofen, carprofen, dexibuprofen, dexketoprofen, fenbufen, fenoprofen, fenoprofen calcium, flunoxaprofen, flurbiprofen, ibuprofen and famotidine; salicylamide, salicyl salicylate, salsalate, methyl salicylate, magnesium salicylate, faislamine, ethenzamide, diflunisal, choline salicylate, choline magnesium salicylate, benorylate, amoxiprin and acetylsalicylic acid; aceclofenac, acemetacin, alclofenac, bromfenac, diclofenac, diclofenac potassium, diclofenac sodium, diclofenac sodium with misoprostol, etodolac, indomethacin, nabumetone, oxametacin, phenylbutazone, proglumetacin, sulindac, tolmetin, tolmetin sodium and zomepirac; mefenamic acid, flufenamic acid, meclofenamic acid, tolfenamic acid and nabumetone; ampyrone, azapropazone, clofezone, kebuzone, dipyrone, mofebutazone, oxyphenbutazone, phenazone, phenylbutazone and sulfinpyrazone; and droxicam, lornoxicam, meloxicam, piroxicam, tenoxicam, and nimesulide. ACTIVITY : Antilipemic; Antiarthritic; Antirheumatic; Neuroprotective. No biological data given. MECHANISM OF ACTION : None given.</p>
申请公布号 DE102012101671(A1) 申请公布日期 2013.08.29
申请号 DE201210101671 申请日期 2012.02.29
申请人 VILLA MELITTA GMBH 发明人
分类号 A61K31/444;A61K31/12;A61K31/165;A61K31/166;A61K31/192;A61K31/196;A61K31/341;A61K31/381;A61K31/402;A61K31/403;A61K31/404;A61K31/415;A61K31/42;A61K31/421;A61K31/423;A61K31/426;A61K31/60;A61K31/603;A61K31/609;A61K31/621 主分类号 A61K31/444
代理机构 代理人
主权项
地址